Micronase

Active Ingredient(s): Glyburide
FDA Approved: * May 1, 1984
Pharm Company: * PHARMACIA AND UPJOHN
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Micronase Overview

Glibenclamide, also known as glyburide, is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfonamide antibiotics. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis).[1] Contents 1 Medical uses 2 Side effects and contraindications 3 Mechanism of action 4 Research 5 Trade names 6 See also 7 References Medical uses It is used in the treatment ...

Read more Micronase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glibenclamide

Recent Micronase Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Micronase: (3 results)

Sorted by National Drug Code

• 0009-0131 Micronase 1.25 mg Oral Tablet by Pharmacia and Upjohn Company
• 0009-0141 Micronase 2.5 mg Oral Tablet by Pharmacia and Upjohn Company
• 0009-0171 Micronase 5 mg Oral Tablet by Pharmacia and Upjohn Company

Other drugs which contain Glyburide or a similar ingredient: (6 results)

• DIABETA Glyburide1 discussion
• GLYBURIDE 62 discussions
• GLYBURIDE (MICRONIZED) Glyburide
• GLYNASE Glyburide29 discussions
• GLUCOVANCE Glyburide + Metformin10 discussions
• GLYBURIDE + METFORMIN 2 discussions

Related Micronase Topics: